Susan Richards Windham-Bannister - 12 Jun 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Susan Richards Windham-Bannister by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
12 Jun 2025
Net transactions value
$0
Form type
4
Filing time
16 Jun 2025, 16:31:56 UTC
Previous filing
28 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Windham-Bannister Susan Richards Director 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM /s/ Susan Richards Windham-Bannister by Dale A. Sander as Attorney-in-Fact 16 Jun 2025 0001713760

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +80,000 $0.000000 80,000 12 Jun 2025 Common Stock 80,000 $2.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.